Estimating physical activity and sedentary behaviour in a free-living environment: A comparative study between Fitbit Charge 2 and Actigraph GT3X by Mikkelsen, M-LK et al.
RESEARCH ARTICLE
Estimating physical activity and sedentary
behaviour in a free-living environment: A
comparative study between fitbit charge 2
and Actigraph GT3X
Marie-Louise K. MikkelsenID1*, Gabriele Berg-Beckhoff2, Peder Frederiksen1,
Graham Horgan3, Ruairi O’Driscoll4, Anto´nio L. Palmeira5, Sarah E. Scott4,
James Stubbs4, Berit L. Heitmann1,6,7,8, Sofus C. Larsen1
1 Research Unit for Dietary Studies, The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital
Region, København, Denmark, 2 Department of Public Health, University of Southern Denmark, Esbjerg,
Denmark, 3 Biomathematics & Statistics Scotland (James Hutton Institute), Aberdeen, Scotland, United
Kingdom, 4 School of Psychology, Faculty of Medicine and Health, University of Leeds, Leeds, England,
United Kingdom, 5 Centro Interdisciplinar para o Estudo da Performance Humana, Faculdade de Motricidade
Humana, Universidade de Lisboa, Lisbon, Portugal, 6 The National Institute of Public Health, University of
Southern Denmark, Copenhagen, Denmark, 7 The Boden Institute of Obesity, Nutrition, Exercise & Eating
Disorders, The University of Sydney, Sydney, Australia, 8 Department of Public Health, Section for General
Practice, University of Copenhagen, Copenhagen, Denmark
* marie-louise.kirkegaard.mikkelsen@regionh.dk
Abstract
Background
Activity trackers such as the Fitbit Charge 2 enable users and researchers to monitor physi-
cal activity in daily life, which could be beneficial for changing behaviour. However, the accu-
racy of the Fitbit Charge 2 in a free-living environment is largely unknown.
Objective
To investigate the agreement between Fitbit Charge 2 and ActiGraph GT3X for the estima-
tion of steps, energy expenditure, time in sedentary behaviour, and light and moderate-to-
vigorous physical activity under free-living conditions, and further examine to what extent
placing the ActiGraph on the wrist as opposed to the hip would affect the findings.
Methods
41 adults (n = 10 males, n = 31 females) were asked to wear a Fitbit Charge 2 device and
two ActiGraph GT3X devices (one on the hip and one on the wrist) for seven consecutive
days and fill out a log of wear times. Agreement was assessed through Bland-Altman plots
combined with multilevel analysis.
Results
The Fitbit measured 1,492 steps/day more than the hip-worn ActiGraph (limits of agreement
[LoA] = -2,250; 5,234), while for sedentary time, it measured 25 min/day less (LoA = -137;
87). Both Bland-Altman plots showed fixed bias. For time in light physical activity, the Fitbit
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measured 59 min/day more (LoA = -52;169). For time in moderate-to-vigorous physical
activity, the Fitbit measured 31 min/day less (LoA = -132; 71) and for activity energy expen-
diture it measured 408 kcal/day more than the hip-worn ActiGraph (LoA = -385; 1,200). For
the two latter outputs, the plots indicated proportional bias. Similar or more pronounced dis-
crepancies, mostly in opposite direction, appeared when comparing to the wrist-worn
ActiGraph.
Conclusion
Moderate to substantial differences between devices were found for most outputs, which
could be due to differences in algorithms. Caution should be taken if replacing one device
with another and when comparing results.
Introduction
To research patterns of physical activity (PA) it is important to have methods that measure
activity accurately [1]. Historically, research into the benefits and consequences of PA rely on
self-reported data, which are prone to inaccuracy and misclassification [1,2], but the develop-
ment of accelerometers has provided opportunities for passive, direct monitoring of habitual
PA in large populations over a long period [3] as well as reducing the burden on participants.
One of the most popular devices for use in research is the ActiGraph, which is often used as
the comparison when testing newer devices [4–6]. Commercial accelerometers have also
recently gained popularity, owing to the development of low-cost devices and cloud storage
capacity, which provides opportunities for surveillance of people in real time [7–9]. Further-
more, they have been found to be useful as intervention tools [10], and the development of
wrist-worn accelerometers have the opportunity to increase compliance [11]. In 2017, a total
of 115.4 million units were sold, with Fitbit being one of the dominating vendors with a market
share of 15.4% [12]. However, the algorithms and technical details are proprietary [13,14] lim-
iting the potential to understand the errors and uncertainty associated with the commercial
activity trackers [9].
Despite the numerous studies investigating the validity of Fitbit devices in a laboratory set-
ting [13,15], less research has been done in a free-living environment, although agreement has
been shown to vary considerably between laboratory and free-living studies, probably because
of the larger variation in activities under free-living conditions [16,17]. Furthermore, most
studies have tested the validity of Fitbit devices on normal weight and young adults [8,14,18–
24] while few studies have been conducted in older or overweight populations [7,25]. Of the
studies testing the validity of wrist-worn Fitbit devices in a free-living setting, the majority
have investigated the agreement on step count against a hip-worn research grade accelerome-
ter, where mostly an overestimation by Fitbits was found [7,8,20–22,26–28]. Fewer studies
have looked at PA levels with reports of both under- and overestimations [7,8,21–23,28]
against a hip-worn research grade device and likewise varying results have been reported on
energy expenditure (EE) [14,19,22,28] against research grade devices at different placements.
As the technical details of Fitbit devices are unknown, continuous confirmation of the validity
of new versions of the activity trackers is required [13].
The aim of this study was to investigate how a popular commercial tracker compare to a
widely used research-grade device by examining the level of agreement on steps, sedentary
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time, time in light activity, time in moderate-to-vigorous PA (MVPA), and EE between the
commercial Fitbit Charge 2 (FB) activity tracker and the research-grade activity tracker Acti-
Graph GT3X (AG) in a free-living environment among middle aged adults with overweight or
obesity. The agreement between devices was assessed with pre-defined settings and algorithms
from the software, thereby investigating whether the FB could easily replace the AG in studies
investigating PA measures.
Materials and methods
This study was part of the baseline examination in the Danish part of the NoHoW study [29],
which is a multi-centre randomised controlled trial focusing on weight loss maintenance in
adults after a clinically significant weight loss. As part of the trial, all participants received a FB
tracker. Participants were also provided with AG devices for a period of one week. This, how-
ever, was an opt-in part of the NoHoW trial and as such, this study is only based on a subset of
the NoHoW participants. The study included adults aged�18 years with a BMI of�25 kg/m2
prior to losing�5% of their body weight during the last 12 months. Participants were excluded
if they were pregnant, breastfeeding, had lost weight due to illness or surgical procedures, been
diagnosed with an eating disorder, been diagnosed with any condition that may interfere with
increasing mild to moderate PA such as walking, or had recently been diagnosed with Type 1
Diabetes. The NoHoW project is registered in ISRCTN (ISRCTN88405328) and approved by
the institutional ethics committees at the participating centres (Capital Region of Denmark: H-
16030495; 8-Mar-2017). The NoHoW study has received funding from the European Union’s
Horizon 2020 research and innovation programme under grant agreement No. 643309.
Instruments
The FB (Fitbit Inc, San Francisco, CA, USA) is a rechargeable commercial tri-axial accelerom-
eter-based activity tracker and wrist-worn heart rate monitor. It collects minute-by-minute
data from which the proprietary algorithms derive step counts, total EE, active minutes, heart
rate, floors climbed, distance and sleep time. These variables are displayed on both the device
itself and on the user’s account in the associated app [30].
The AG (ActiGraph, Pensacola, FL, USA), is a research-grade tri-axial accelerometer. It is
small, lightweight (27 g), and rechargeable, and typically worn at the waist on an elastic band.
In the associated ActiLife software, total steps, activity energy expenditure (AEE), Metabolic
Equivalent of Task (MET) scores and PA levels (sedentary, light, moderate, vigorous, very vig-
orous) can be computed via different algorithms and cut-points [31,32]. These have originally
been developed for the AG to be placed on the hip. Though validated AEE algorithms for wrist
usage are not available in the ActiLife software, the hip algorithms have been adapted for wrist
usage, which can be indicated in the software. However, these scaled algorithms have not yet
been validated [33], and discrepancy has been found on EE when comparing measures from
the two device locations [34]. Thus, in the primary analyses we compared FB measures to mea-
sures from AG placed on the hip. However, as pointed out elsewhere [35,36], comparing
movement at different bodily locations will lead to discrepancies due to the different move-
ment patterns of these anatomical locations. Therefore, we also examined whether wearing the
AG on the wrist provided different levels of agreement with the FB.
Procedures
This subset of NoHoW participants attended the baseline visit in March-June 2017. Aim and
procedures were explained to participants and both written and oral informed consent was
obtained. Standing height was measured to the nearest 0.1 cm, using a stadiometer (Seca 704s;
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SECA, Germany), and weight to the nearest 0.1 kg using a digital weighing scale (Seca 704s;
SECA, Germany). Body mass index (BMI) was calculated as kg/m2.
All accelerometer devices were initialised via the proprietary software with participants’
age, gender, height, and weight information. A Fitbit account was made for each participant
and the app was downloaded to their personal smartphone or tablet. The FB device was
updated to the latest firmware (version 22.53.4) and placed on the preferred wrist of the partic-
ipant. The Fitbit app was configured to reflect the chosen wrist. Two AG instruments were
initialised for each participant using the ActiLife Software (version 5.9.2.0); one for the hip
(AGhip) and one for the wrist (AGwrist). The AGhip was placed on the right side of the body,
while AGwrist was placed on the same wrist as the FB device. The devices were initialised to col-
lect data for seven consecutive days with a sampling frequency of 30 Hz and an epoch length
of five seconds without the low-frequency extension. Participants were instructed to wear the
devices for all seven days, excluding nights, and fill out a wear-time log.
Data processing
Data from both AG devices were downloaded using ActiLife and wear time validation was per-
formed. Non-wear time was defined as 90 consecutive minutes of zero counts, allowing for up
to two-minute interruptions of non-zero counts [37]. A minimum of 10 hours of wear time
was necessary for a day to be considered valid and a minimum of three valid days was required
to be included in analyses. To be able to compare FB data to both AGhip and AGwrist, data was
excluded from all devices if either AGhip or AGwrist indicated periods of non-wear. Non-wear
time from all devices were also removed according to the log filled out by each participant. To
exclude possible instances where one tracker was worn but another not, days were also
excluded from the analysis, if less than 1500 steps on a device were accumulated over the entire
day. This criterion of<1500 was based on a study by Tudor-Locke et al who compared acceler-
ometers located at different positions [38].
Physical activity outputs
For all AG outputs, the scoring options already available in the ActiLife software were utilised.
The vector magnitude (VM =
p
((Axis 1)2+(Axis 2)2+(Axis 3)2)) [31,39] was used and for
AGwrist, the “Worn on wrist” option in ActiLife was applied. Total step count was calculated
through the proprietary software for each device. For PA levels, the cut-points for AGhip were
<200 VM counts/min for sedentary, 200–2689 VM counts/min for light and�2690 VM
counts/min for MVPA [40,41]. For AGwrist the chosen cut-points were<2000 VM counts/min
for sedentary, 2000–7999 VM counts/min for light and�8000 VM counts/min for MVPA
[41]. These were manually applied in ActiLife as no predefined cut-points were available. For
FB, the PA levels are scored into 4 categories (sedentary, lightly active, fairly active, and very
active), and it was assumed that combining fairly active and very active would correspond a
MVPA category [21]. When assessing EE from the AG, the Freedson VM3 Combination algo-
rithm in the ActiLife software was used as this algorithm was the one available in the ActiLife
software that uses information from all three axes and is developed for data from an adult pop-
ulation [40,42]. The EE output from FB is provided in total calories, while the output for AG is
only the active calories. Thus, the estimated basal metabolic rate calculated by the FB was sub-
tracted from the total EE variable from FB to create an AEE variable comparable to AG.
Statistical analysis
Agreement between devices was assessed using Bland-Altman plots to calculate absolute bias
and 95% limits of agreement (LoA). The Bland-Altman plot was originally developed for data
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with two sets of measurements on one occasion, and hence the mean difference and LoA are
quite simple to calculate [43]. However, that would require the measurements for each person
to be grouped into weekly averages and some of the day-to-day variation is lost [44,45]. To
keep the daily variation in the data, observations were not aggregated into weekly averages per
participant, but each day consisted of a paired observation. As such, observations would be
naturally clustered within participants and therefore, to take this clustering into account, a
multilevel analysis with a random term for participant ID and no fixed effects was performed
to assess mean difference and LoA. Bias was assessed though visual inspections of the plots. All
analyses were performed using Stata SE 15.0 (StataCorp LP, College Station, Texas, USA;
www.stata.com).
Sensitivity analyses. A sensitivity analysis was performed where FB was compared to
AGwrist instead of AGhip. To compare how the agreement would change, a replicate of the
main analysis was conducted using the AGwrist data. Furthermore, most studies comparing
activity trackers with a duration of>1 day aggregate data into weekly averages [7,8,23,27,28].
It is likely that this would provide different results as some of the variation disappears [46]. To
investigate this, an additional analysis was conducted where the observations for FB and AGhip
from the main analysis were grouped into weekly averages and a traditional Bland-Altman
plot constructed to examine how much the results change.
Results
Out of 536 recruited NoHoW participants in Denmark, 143 attended the baseline visit in
March-June 2017. Of these, 60 participants agreed to take part in this study. After exclusion on
non-compliance to protocol and wear-time criteria, the analysis included 41 participants with
a total of 256 valid days and an average of 6.2 days recorded per participant. Participant char-
acteristics can be found in Table 1.
Compared to AGhip, FB provided higher mean measures on steps, time in light activity and
AEE, and lower mean measures on time in sedentary and MVPA. Compared to AGwrist, FB
provided higher mean measures on time in sedentary and lower mean measures on steps, time
in MVPA, and AEE (Table 2).
Assessing agreement
Bland-Altman plots with mean difference and LoAs comparing FB to AGhip for each variable
are presented in Fig 1. FB measured 1,492 more daily steps than the AGhip (LoA = -2,250;
5,234). The Bland-Altman plot (Plot A) displayed an even spread of observations around the
mean difference and thus no proportional bias. The difference in sedentary behaviour between
devices was small with a bias of -25 min/day (LoA = -137; 87) (Plot B). For time in light activ-
ity, FB measured 59 min/day (LoA = -52; 169) more than AGhip. In the Bland-Altman plot
(Plot C) the observations form a slight upwards trend, suggesting a small increasing positive
Table 1. Participant characteristics.
All (n = 41) Men (n = 10) Women (n = 31)
Age (years) 47.6 (10.4) 48.4 (11.0) 47.4 (10.4)
BMI (kg/m2) 29.4 (4.8) 30.4 (6.0) 29.1 (4.4)
Valid days per participant 6.2 (1.1) 6.4 (1.0) 6.2 (1.2)
Daily wear time per participant (hours) 14.1 (1.1) 14.6 (1.1) 13.9 (1.1)
Results presented as mean (SD)
https://doi.org/10.1371/journal.pone.0234426.t001
PLOS ONE Comparison between Fitbit Charge 2 and Actigraph GT3X
PLOS ONE | https://doi.org/10.1371/journal.pone.0234426 June 11, 2020 5 / 13
bias with higher daily time in light activity. For time spent in MVPA, there was a mean differ-
ence of -31 min/day (LoA of -132; 71). Due to the funnel structure of the plot, it can be seen,
that as time in MVPA increased, the difference between devices increased (Plot D). Further-
more, an unusual distribution of observations in the Bland-Altman plots for MVPA could be
seen. Also, for AEE (Plot E), high discord was found between FB and AGhip. FB measured a
Table 2. Instrument variability.
Fitbit AGhip AGwrist
Included days [n] 256
Mean (SD) Min Max Mean (SD) Min Max Mean (SD) Min Max
Steps [n/day] 10,209 (4,742) 1,687 25,493 8,753 (4,324) 1,697 23,217 11,659 (3,821) 3,116 22,458
Sedentary [min/day] 551 (122) 234 878 574 (118) 228 900 376 (111) 104 719
Light [min/day] 242 (84) 73 511 183 (64) 67 394 92 (28) 28 277
MVPA [min/day] 59 (53) 0 245 91 (50) 0 268 380 (106) 158 672
AEE [kcal/day] 1,105 (535) 205 3,129 701 (397) 143 2,219 2,660 (1,177) 158 7,261
MVPA, moderate-to-vigorous physical activity; AEE, activity energy expenditure
https://doi.org/10.1371/journal.pone.0234426.t002
Fig 1. Bland-Altman plots of differences between wrist-worn Fitbit Charge 2 and hip-worn ActiGraph against the
mean on: (A) Steps, (B) Time in sedentary, (C) Time in light activity, (D) Time in MVPA, and (E) AEE. The bold lines
represent mean of the differences between devices, the dashed lines are the 95% limits of agreement. The numbers in
the plot represent each subject. Abbreviation’s: FB, Fitbit Charge 2; AGhip, ActiGraph GT3X worn on the hip; MVPA,
moderate-to vigorous physical activity; AEE, active energy expenditure.
https://doi.org/10.1371/journal.pone.0234426.g001
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mean of 408 kcal/day (LoA was -385; 1,200) more than AGhip. Furthermore, as the kcal
increased the agreement between devices decreased.
Sensitivity analyses
When comparing FB to AG placed on the wrist instead of the hip a generally higher discord
between devices was observed (S1 Fig). FB measured 1,433 (LoA -5,875; 3,010) fewer daily
steps than AGwrist. As the number of steps increased, so did the difference between devices.
For time in sedentary, the mean difference between devices was 173 min/day (LoA = 32; -314).
For time in light activity, the difference between devices was 150 min/day (LoA = -23; 323).
The slight increasing positive bias seen in the plot when comparing FB and AGhip became
much more pronounced when comparing to AGwrist. For time spent in MVPA, the mean dif-
ference was -320 min/day (LoA = -523; -117) when compared to AGwrist. For AEE, the FB
measured 1,563 kcal/day (LoA = -3,340; 215) less than AGwrist. In the Bland-Altman plot, the
observations form a downwards trend, suggesting an increasing negative bias with higher daily
AEE.
Analyses of weekly averages for all variables comparing FB to AGhip were also performed
and presented as Bland-Altman plots (S2 Fig). The mean differences were 1,500 daily steps
(LoA = -1,237; 4237), -25 min/day (LoA = -121; 70) for time in sedentary, 59 min/day (LoA =
-28; 145) for time in light activity, -30 min/day in MVPA (LoA = -111; 51), and 408 kcal/day
(LoA = -240; 1056) for AEE.
Discussion
The present study compared several physical activity estimates from a commercial activity
tracker, FB, to a research grade accelerometer, AG, worn on the hip and wrist. When com-
pared to the AGhip, a moderate error was observed for steps and substantial error was observed
for AEE and MVPA. Furthermore, for MVPA and AEE the disagreement between the com-
mercial and the research grade devices seemed to increase as the mean measure increased.
Similar to these findings, most but not all other studies comparing a wrist-worn Fitbit
device to AG also found that a Fitbit measured more steps compared to AG. Chu et al. [26]
and Alharbi et al. [7] reported that the Fitbit Flex measured 1,300 steps/day and 1,461 steps/
day more than AG, respectively. Brewer et al. [23], who utilised a protocol of testing several
different Fitbit devices, found that they measured 1,365 steps/day more than AG. Similarly,
Farina and Lowry [27] and Hargens et al. [28] reported that the Fitbit Charge measured 2,690
steps/day and 1,695 steps/day more than AG, respectively, while Sushames et al. [22], con-
trarily reported that Fitbit Flex measured less daily steps by 3,313. It should be noted that in
this latter study, activity was only measured for a single day, which may not give the full picture
of variety in activities in daily life. Furthermore, all these studies, except for two [7,27] tested
validity on young, normal weight adults.
For time in sedentary behaviour, the present results contrast with previous studies, which
indicated larger discord. Dominick et al. [8] reported a difference of 26%/day and Reid et al.
[21] reported a difference of 1.28 hours/day when comparing Fitbit Flex to AG. The studies by
Dominick et al. [8] and Reid et al. [21] also reported results for in time in light activity, where
they found differences of -34%/day and -5.12 min/day, respectively, when comparing Fitbit
Flex to AG. These are both in the opposite direction of the present results. For MVPA, the cur-
rent results extend on previous research by Reid et al. [21] who found a mean difference of
-57.5 min/day between Fitbit Flex and AG. However, no substantial difference was found by
Brewer et al. [23] and Hargens et al. [28] who reported a difference of 0.81 min/day and 5.9
min/day, respectively.
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Only two other studies have compared a wrist-worn Fitbit to AG on AEE. Sushames et al.
[22] reported that the Fitbit Flex overestimated AEE by 269 kcal/day, while Hargens et al. [28]
reported that Fitbit Charge overestimated AEE by 580 kcal/day. Both are similar to the results
found in the current study.
Our results revealed that there was lower agreement on all outputs between FB and AGwrist
than between FB and AGhip. To our knowledge, no previous studies have compared FB to a
wrist-worn AG. However, a study by Tudor-Locke et al. [38] found that a waist-worn AG per-
formed better in measuring steps than an AG worn on the wrist when compared to manual
counting, and that the wrist-worn AG over-counted steps in a free-living setting when com-
pared to the waist-worn AG. Furthermore, the plots showed systematic bias on all wrist out-
puts except sedentary time. The major reason for the discrepancies on all outputs is probably
that cut-points and algorithms for the AG available in the software have been developed with
the purpose of hip placement [36,40,47], and therefore may not be applicable for a wrist-worn
AG. This is further evident by the mean time in MVPA of approx. 6 hours per day measured
by the AGwrist. This is much larger than for the other devices, and in contrast to official recom-
mendations and estimates [48]. The suggestion that comparisons should be done with devices
at same bodily locations [35], though sensible, seems to provide more problems than benefits,
at least if the comparison device is an AG.
As expected [46], using the weekly averages per participant as one observation instead of
keeping each day as separate observations provided roughly the same mean difference for all
variables, but narrower LoAs. Furthermore, the observation distribution in the Bland-Altman
plots remained, though being less pronounced. Agreement studies for accelerometers often
use the weekly averages [7,49,50], which may make the agreement appear falsely high. Depend-
ing on the intended use of the given device, and whether one wishes to use estimates of the
day-to-day variation, this may be an issue of relevance.
Method agreement studies have been criticised for either using the wrong type of analysis,
or not reporting the results of Bland-Altman plot adequately [51]. In addition to using Bland-
Altman plots as the analytical method, a strength of the present study is keeping the observa-
tions as repeated measures for each subject and using multilevel analysis for calculating the
LoA. This has rarely been done in earlier agreement studies [52]. In fact, to our knowledge this
is the first study to use this method for comparing a Fitbit device to AG outputs.
Our study is limited by some technical details. Firstly, the cut-points for classifying PA lev-
els on AG varies a lot and choosing the right one becomes quite arbitrary. In fact, Loprinzi
et al. [53] reviewed the previous literature and found 12 different MVPA cut-point thresholds
ranging from 191 to 3285 counts/min. Depending on the cut-point applied to their own data
set, the prevalence of adults meeting the official recommendations ranged as much as from
4.7% to 97.5%. Furthermore, the cut-points chosen for AGhip in this study [40] were calibrated
under laboratory settings and in a population with a mean age of 28 years, while cut-points
chosen for AGwrist were based on a study population with a mean age of 71.9 years [41]. Thus,
the chosen cut-points may not be applicable in the given population, of middle aged over-
weight or obese adults in a free-living context, and this could potentially explain some of the
difference when comparing FB to AGhip and AGwrist. Furthermore, the study providing these
cut-points was not a validation study aiming at finding the most accurate cut-points for wrist
usage, but the study did find that these cut-points correlated best with estimates from hip
usage. For the FB, there is not much information on how the PA levels are defined, other than
the fact that active minutes are earned for activities� 3 METs and may only be registered
when there are more than 10 minutes of continuous activity [54], which is quite different from
the AG, which is initialised to collect data in five seconds epochs. It is likely this difference in
classifying PA levels in the devices have contributed to the level of mean difference in outputs
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and it may also be the reason for the distinct distribution of observations in the Bland-Altman
plots for MVPA. It is very likely that applying the 10 minutes criteria to the AG as well, would
have altered these results.
Secondly, there is no information on the specific algorithm used for calculating EE by the
FB device. However, a recent meta-analysis showed that devices with optical heart rate sensors
are generally more accurate in estimates of energy expenditure. This may indicate that heart
rate is incorporated in to the FB algorithms [55], which is not an available feature in the AG.
In addition, as with the cut-points, the algorithm used for the AG was developed in a labora-
tory setting with a sample population with young and fit people [40]. This may not be as pre-
cise for a middle-aged, heavier population in a free-living setting as it has been found that
higher BMI and slower speed is associated with decreasing accuracy of accelerometer output
[7,13,14,18]. Thus, results for the PA levels and AEE in the present study should be interpreted
with caution as it is not possible to determine whether the difference between devices is
between the actual devices or disparities in cut-points and algorithms. It should be noted that
the algorithms and cut-points applied to AG in this study were chosen from those already pro-
vided in the ActiLife software. Using raw data and more advanced algorithms and some vali-
dated for wrist usage [56,57], it could be beneficial to investigate, how the FB matches different
algorithms and cut-points applied to the AG. However, that was beyond the scope of this
paper. Future research should further consider that PA outputs of any device could be affected
by firmware updates that change the propriety algorithms and settings [58].
Thirdly, as in other studies [7,21,26], the AG is here used as the device to which the newer
FB tracker is evaluated against, yet caution should be taken. The AG is not a true criterion
measure on PA outputs in a free living context and varying results have been found when test-
ing the validity of AG against e.g. manual counted steps [34,59–61]. For EE, doubly labeled
water is considered the gold standard [62] and for measuring steps, it has been suggested that
the StepWatch [63,64] is the most accurate while some have attempted the use of video-record-
ing [65]. Neither the doubly labeled water nor video recordings seem feasible options in many
situations, and for the other PA outputs no true gold standard exists. Thus, the use of AG as a
comparison method in the present study can, as such, be considered a limitation if one wishes
to predict the true accuracy of the test method. However, in the present study the aim was not
a test of the true accuracy of PA outputs, but merely an investigation of how different device
agree, and if it was possible to replace one with the other.
Even though the study population consisted primarily of middle aged overweight and obese
women, the present results may be better representative of the general population with respect
to BMI and age compared to many other validation studies that use convenience samples from
colleges and universities and consisted of young and fit subjects. It should, however, be noted
that this study included people, who had either just lost weight or were in the process of losing
weight. This may have influenced their PA levels, and hence made our sample less representa-
tive of the general population.
Conclusions
Moderate to substantial differences were found for steps, light activity, MVPA, and AEE when
comparing outputs from the commercial FB device to the research grade hip-worn AG. The
results of this study expand on the existing results from previous literature investigating the
validity of wrist-worn Fitbit devices. Considering these discrepancies between FB and AG, the
FB may not be suitable for clinical research, but be more appropriate for studies utilising the
immediate feedback function and be helpful in setting goals and monitoring individual prog-
ress. A substantial limitation in the use of Fitbit in research is the lack of knowledge about how
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these devices work. If using either the ActiGraph or Fitbit device, researchers should consider
the bodily location of the device and be aware that algorithms, cut-points and other criteria
applied to the devices will highly influence the results, especially if comparing results to other
studies. It would also be beneficial for comparing purposes if future studies report information
about specific models and firmware versions. Furthermore, as long as the technical details of
Fitbit devices are not open to researchers, investigating the validity is difficult as it is not possi-
ble to know if the observed differences are results of the device itself or, more likely, differences
in algorithms.
Supporting information
S1 Fig. Bland-Altman plots of differences between wrist-worn Fitbit Charge 2 and wrist-worn
ActiGraph against the mean on: (A) Steps, (B) Time in sedentary, (C) Time in light activity,
(D) Time in MVPA, and (E) AEE. The bold lines represent mean of the differences between
devices, the dashed lines are the 95% limits of agreement. The numbers in the plot represent
each subject. Abbreviation’s: FB, Fitbit Charge 2; AGhip, ActiGraph GT3X worn on the hip;
MVPA, moderate-to vigorous physical activity; AEE, active energy expenditure.
(TIF)
S2 Fig. Bland-Altman plots of differences between wrist-worn Fitbit Charge 2 and hip-worn
ActiGraph against the mean using weekly averages on: (A) Steps, (B) Time in sedentary, (C)
Time in light activity, (D) Time in MVPA, and (E) AEE. The bold lines represent mean of the
differences between devices, the dashed lines are the 95% limits of agreement. The numbers in
the plot represent each subject. Abbreviation’s: FB, Fitbit Charge 2; AGhip, ActiGraph GT3X
worn on the hip; MVPA, moderate-to vigorous physical activity; AEE, active energy expendi-
ture.
(TIF)
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